Various tumor markers were identified, including calretinin (CALB2), mesothelin (MSLN), type III collagen (COL3A1), and secretory leukocyte peptidase inhibitor (SLP1) (Gueugnon et al., 2011). This evidence concerns the gene CALB2 and neoplasm.